Imaging in 2020 VI: Imaging Biopathways
September 17-21, 2009
2009
Program Chairs: Bonnie Sloane and Mike Tweedle
Organizers: Thomas Meade and Daniel Sullivan
Session 1: Engineering
Chair: Tom Budinger, Lawrence Berkeley National Lab
The future of current imaging modalities
John Gore, Vanderbilt University
Emerging and future technology and its impact on biomedical imaging
Greg Auner, Wayne State University
Session 3: Biopathways I
Imaging of angiogenesis inhibitor actions on tumors
Donald McDonald, University of California, San Francisco
MRI angiogenesis
Michal Neeman, Weizmann Institute
PET angiogenesis
Markus Schwaiger, Technical University – Munich
Session 5: Chemistry II
Chair: Tom Meade, Northwestern University
Tumor-selective optical and multimodal imaging with porphyrazines
Brian Hoffman, Northwestern University
Relaxivity of 100 for a stable Gd complex
Ken Raymond, University of California, Berkeley
Session 7: Ultrasound Agents
Chair: Kathy Ferrara, University of California, Davis
Targeted ultrasound agents
Alexander Klibanov, University of Virginia
Advances in technology for ultrasound contrast imaging
Paul Dayton, University of North Carolina / North Carolina State University
Session 9: Animal Models
Chair: Dan Sullivan, Duke University
Development of animal models
Terry Van Dyke, National Cancer Institute at Frederick
Mouse models of cancer for optical imaging
David Kirsch, Duke University
Session 2: Chemistry I
Chair: Mike Tweedle, The Ohio State University
Imaging and dynamics of supramolecular assemblies
Akira Harada, Osaka University
Multimodality imaging agents
Angie Louie, University of California, Davis
Session 4: Biopathways II
Chair: Adrian Nunn, Bracco Research USA
New advances in multiphoton imaging of tumor metastasis
John Condeelis, Albert Einstein College of Medicine
Deep tissue imaging of cancer: Collective invasion and resistance to therapy
Peter Friedl, Nijmegen Center for Molecular Life Sciences
Session 6: Pharmaceuticals
RNA interference (RNAi): Challenges and Opportunities
Dan Silverman, University of California, Los Angeles
Keynote Address
Improving in vivo and clinical imaging with activatable cell-penetrating peptides
Roger Tsien, University of California, San Diego
Session 8: Microscopy
Chair: Bob Gillies, Moffitt Cancer Center
Optical molecular imaging for point-of-care diagnostics: Endoscopic microscopy
Rebecca Richards-Kortum, Rice
Nanoscale compositional imaging of cells
Richard Leapman, National Institutes of Health
Session 10: Targeted Agents
Chair: Sarah Nelson, University of California, San Francisco
Magnetic labeling for cellular MR: Trials and tribulations
Joe Frank, National Institutes of Health
Small molecule probes of protease function: Applications to molecular imaging
Matthew Bogyo, Stanford University